MedPath

BioGend Therapeutics Co., Ltd.

🇹🇼Taiwan
Ownership
-
Employees
-
Market Cap
-
Website

Clinical Trials

3

Active:1
Completed:1

Trial Phases

1 Phases

Not Applicable:3

Drug Approvals

0

Drug Approvals

No drug approvals found

This company may not have drug approvals in our database

Clinical Trials

Distribution across different clinical trial phases (3 trials with phase data)• Click on a phase to view related trials

Not Applicable
3 (100.0%)

The Clinical Outcome of BiCRI in the Treatment of Chondral and Osteochondral Lesions

Not Applicable
Recruiting
Conditions
Articular Cartilage Disorder of Knee
First Posted Date
2023-06-29
Last Posted Date
2023-06-29
Lead Sponsor
BioGend Therapeutics Co.Ltd
Target Recruit Count
60
Registration Number
NCT05924763
Locations
🇨🇳

En Chu Kong Hospital, New Taipei City, Taiwan

OIF/β-TCP in Patients With Open Tibial Fractures in Need of Bone Grafting

Not Applicable
Active, not recruiting
Conditions
Tibia Fracture
First Posted Date
2021-07-14
Last Posted Date
2024-04-24
Lead Sponsor
BioGend Therapeutics Co.Ltd
Target Recruit Count
35
Registration Number
NCT04960722
Locations
🇨🇳

BioGend Therapeutics, Taipei, Taiwan

BiPhasic Cartilage Repair Implant (BiCRI) IDE Clinical Trial - Taiwan

Not Applicable
Completed
Conditions
Chondral or Osteochondral Lesion of Medial Femoral Condyle
Chondral or Osteochondral Lesion of Lateral Femoral Condyle
Chondral or Osteochondral Lesion of Trochlea
First Posted Date
2011-11-22
Last Posted Date
2022-01-20
Lead Sponsor
BioGend Therapeutics Co.Ltd
Target Recruit Count
92
Registration Number
NCT01477008
Locations
🇨🇳

Taipei Medical University-Shuang Ho Hospital, Taipei county, Taipei, Taiwan

🇨🇳

Show Chwan Memorial Hospital (SCMH), Changhua, Taiwan

🇨🇳

Chang Gung Memorial Hospital Kaohsiung (CGMH-KS), Kaohsiung, Taiwan

and more 8 locations

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.